ITOS Historical PE Ratio image   This ITOS PE ratio history page last updated 5/22/2024
ITOS PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/10/2024
17.44-1.07-3.78NA
Q4 2023
3/6/2024
11.88-0.85-3.15NA
Q3 2023
11/7/2023
10.65-0.90-1.76NA
Q2 2023
8/8/2023
12.17-0.96-0.83NA
Q1 2023
5/10/2023
14.58-0.440.2852.1
Q4 2022
3/15/2023
15.730.542.546.2
Q3 2022
11/10/2022
20.560.036.883.0
Q2 2022
8/10/2022
27.090.158.713.1
Q1 2022
5/12/2022
18.571.827.812.4
Q4 2021
3/23/2022
31.924.885.605.7
Q3 2021
11/10/2021
29.431.860.29101.5
Q2 2021
8/12/2021
24.91-0.75-2.05NA
Q1 2021
5/13/2021
22.36-0.39-30.79NA
Q4 2020
3/24/2021
30.86-0.43NANA
Q3 2020
11/12/2020
23.19-0.48NANA
Q2 2020
9/1/2020
28.07-29.49NANA
ITOS Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/10/2024
17.44-1.07-4.28NA
Q4 2023
3/6/2024
11.88-0.85-3.40NA
Q3 2023
11/7/2023
10.65-0.90-3.60NA
Q2 2023
8/8/2023
12.17-0.96-3.84NA
Q1 2023
5/10/2023
14.58-0.44-1.76NA
Q4 2022
3/15/2023
15.730.542.167.3
Q3 2022
11/10/2022
20.560.030.12171.3
Q2 2022
8/10/2022
27.090.150.6045.1
Q1 2022
5/12/2022
18.571.827.282.6
Q4 2021
3/23/2022
31.924.8819.521.6
Q3 2021
11/10/2021
29.431.867.444.0
Q2 2021
8/12/2021
24.91-0.75-3.00NA
Q1 2021
5/13/2021
22.36-0.39-1.56NA
Q4 2020
3/24/2021
30.86-0.43-1.72NA
Q3 2020
11/12/2020
23.19-0.48-1.92NA
Q2 2020
9/1/2020
28.07-29.49-117.96NA
Quotes delayed 20 minutes

Email EnvelopeFree ITOS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ITeos Therapeutics (ITOS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

IVC PE Ratio History
IVVD PE Ratio History
JAGX PE Ratio History
JANX PE Ratio History
JAZZ PE Ratio History
JNCE PE Ratio History
JNJ PE Ratio History
KA PE Ratio History
KALA PE Ratio History
KALV PE Ratio History
On this page we presented the ITOS PE Ratio History information for ITeos Therapeutics' stock. The average ITOS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 38.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ITOS PE ratio history based on this TTM earnings result method is 24.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ITOS PE ratio history result, against the recent PE: when this page was posted on 5/21/2024, the most recent closing price for ITOS had been 18.03, and the most recent quarterly earnings result, annualized, was 2.16. Meanwhile, the most recent TTM earnings summed to 0.28. From these numbers, we calculate the recent ITOS PE on 5/21/2024 based on annualized quarterly EPS was 8.3. Based on ITOS's history, that recent PE is low relative to the historical average, with the recent PE 78.5% lower than the historical average PE across our data set for ITeos Therapeutics. Looking at the recent ITOS PE on 5/21/2024 based on TTM EPS, we calculate the ratio at 64.4. Based on ITOS's history, that recent PE is elevated relative to the historical average, with the recent PE 158.6% higher than the historical average PE across our ITeos Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ITOS or any other given stock, valuation analysis for ITOS can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate ITeos Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ITOS. Thanks for visiting, and the next time you need to research ITOS PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: SLTC Split History, Institutional Holders of VHC, Institutional Holders of BIF.

 

ITOS PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.